MULTI-001 Nivolumab v6
MULTI-002 Carboplatin and etoposide v1 MULTI-003 Pembrolizumab v5
MULTI-018 Larotrectinib v1
SKI-009 Ipilimumab & Nivolumab v3
SKI-010 Dabrafenib & Trametinib v2
SKI-011 Avelumab for Merkel Cell Carcinoma v2 SKI-012 Talimogene laherparepvec v1
SKI-014 Encorafenib & Binimetinib v1
SKI-015 Cemiplimab v1
